2025-522409-39-00Not yet recruitingPhase 1
Immune Cell Therapy for People with Early, Active Multiple Sclerosis
Source: EU CTIS (euclinicaltrials.eu) · Last updated 24 Jul 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 2 Apr 2026
- Start date
- 1 Jul 2026
- Lead sponsor
- Medizinische Hochschule Hannover
- Diseases
- Multiple sclerosis
- EU CT number
- 2025-522409-39-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 10
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medizinische Hochschule Hannover | Hanover | Germany | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.